| Name | Title | Contact Details |
|---|
Call 4 Health is a leading medical call center and nurse triage service with a genuine understanding of the patient`s perspective. Delivering compassionate commitment with quality medical solutions to our clients since 1997, Call 4 Health has a keen understanding of what it is like to face trauma and has developed a sound system to seamlessly balance professionalism with compassion. Our altruistic approach places patients and their families first by using state-of- the-art technological initiatives to process up to 2,500 calls simultaneously. Call 4 Health is always ready with real solutions consistent with the needs of both the client and the patient.
NxStage is more than just a company; we are leading the renal revolution. By our own design, we`re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success is inspiring patients and providers.
AGS Health is an analytics-driven, technology-enabled revenue cycle management company serving leading healthcare providers across the U.S. AGS Health partners with clients to tackle RCM data challenges; advising them on what questions to ask and helping them find answers.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Ltc Providers is a Sullivan, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.